Invention Grant
- Patent Title: Chemical compounds
-
Application No.: US16631218Application Date: 2018-07-20
-
Publication No.: US11299467B2Publication Date: 2022-04-12
- Inventor: David Thomas Davies , Simon Leiris , Nicolas Sprynski , Martin Everett , Magdalena Zalacain
- Applicant: Antabio SAS
- Applicant Address: FR Labege
- Assignee: Antabio SAS
- Current Assignee: Antabio SAS
- Current Assignee Address: FR Labege
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Agent Lars H. Genieser
- Priority: EP17305973 20170721,EP18290003 20180108,EP18150903 20180109
- International Application: PCT/EP2018/069827 WO 20180720
- International Announcement: WO2019/016393 WO 20190124
- Main IPC: C07D277/587
- IPC: C07D277/587 ; A61K31/407 ; A61K31/437

Abstract:
The invention relates to a compound which is a thiazole derivative of Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, Formula (A), Z, L, X, m, n and p are as defined herein. The compounds are useful in the treatment and prevention of bacterial infection. The invention also relates to combinations of the compound of Formula (I) with further active agents.
Public/Granted literature
- US20200339526A1 CHEMICAL COMPOUNDS Public/Granted day:2020-10-29
Information query